Delivery Order SPE2DR25D7066-SPE2DR26F7ZTR
Award Date 1/9/26
Potential Completion Date 1/12/26
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,150.20 for 5,000 units of Thrombin-JMI vials on December 30, 2025, with completion scheduled for December 31, 2025. This firm fixed-price contract, which was competitively awarded without a set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Thrombin is a critical hemostatic agent used in surgical and medical applications to control...
- The Defense Logistics Agency awarded a $7,933.78 delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Thrombin-JMI, a hemostatic agent used in surgical and medical applications. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of November 3, 2025. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Thrombin-JMI 5,000 unit vials. This competitively awarded, non-set-aside contract carries a ceiling value of $7,615.26 under a firm fixed-price delivery order arrangement, with an ultimate completion date of September 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,150.20 to AmerisourceBergen Drug Corp for 5,000 units of Thrombin-JMI vials. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on December 30, 2025, with an ultimate completion date of December 31, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for Thrombin-JMI 5,000 Units Vials with a ceiling value of $22,319.95. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for ultimate completion on November 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Thrombin-JMI 5,000 unit vials, with a ceiling value of $1,533.12. This is a firm fixed-price delivery order executed under a competitive, non-set-aside procurement. The contract is scheduled for ultimate completion by December 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Thrombin-JMI 5,000 Units Vials with a ceiling value of $1,451.48. This firm fixed price delivery order, which represents a child contract under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by November 28, 2025. The award was not designated as a set-aside contract,...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 15, 2025, for the supply of Thrombin-JMI 5,000 Units vials with a ceiling value of $1,188.00. This is a firm fixed-price delivery order issued under a competitive, non-set-aside procurement by the Medical Supply Chain, which operates under the Defense Logistics Agency within the Department of Defense. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,031.56, is for the delivery of 20,000 unit vials of Thrombin-JMI, a medical product used for surgical procedures. This is a firm fixed-price delivery order contract with a completion date of September 16, 2022. The contract does not have a set-aside designation, indicating open competition....
- This federal contract award, with a ceiling value of $41,040.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 20,000 unit vials of Thrombin-JMI, a pharmaceutical product, with a performance period extending through May 9, 2025. This contract is not set-aside and is awarded as a firm-fixed-price contract. AmerisourceBergen Drug Corp holds a...